| Name | transgelin |
| Description | This gene encodes a shape change and transformation sensitive actin-binding protein which belongs to the calponin family. It is ubiquitously expressed in vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. The encoded protein is thought to be involved in calcium-independent smooth muscle contraction. It acts as a tumor suppressor, and the loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity. The encoded protein has a domain architecture consisting of an N-terminal calponin homology (CH) domain and a C-terminal calponin-like (CLIK) domain. Mice with a knockout of the orthologous gene are viable and fertile but their vascular smooth muscle cells exhibit alterations in the distribution of the actin filament and changes in cytoskeletal organization. [provided by RefSeq, Aug 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTransgelin (TAGLN), also known as SM22, is a 22‐kDa actin‐binding protein that plays a central role in regulating cytoskeletal architecture and smooth muscle cell differentiation. In normal tissues it functions as an early marker of smooth muscle differentiation, contributing to calcium‐independent contractility, cell shape modulation, and tissue remodeling. TAGLN expression is tightly controlled by signals such as transforming growth factor–β (TGF–β)/Smad3 and by mechanical cues that influence actin filament stabilization, underscoring its importance in maintaining the differentiated contractile phenotype of vascular and visceral smooth muscle cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn oncological settings, TAGLN demonstrates a complex, context‐dependent behavior. Numerous studies have reported that loss or downregulation of TAGLN in epithelial cancers – including colorectal, prostate, and breast carcinomas – is associated with early tumor progression and has been interpreted as evidence for a tumor‐suppressor role. Conversely, in some advanced tumor types and in specific cellular compartments (for example, within reactive tumor stroma or even in cancer stem cells), maintained or re‐induced TAGLN expression has been linked to enhanced cell migration, invasion, and resistance to cytotoxic therapies. These observations suggest that, while diminished TAGLN expression may contribute to malignant transformation, its re‐expression in later stages can promote metastatic potential through modulation of actin dynamics and interaction with oncogenic regulators such as p53 and PTEN."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in muscle physiology and tumor cell behavior, TAGLN has emerged as a promising diagnostic and prognostic biomarker. Differential expression patterns—such as its contrasting levels in neoplastic epithelial cells versus the tumor‐induced reactive stroma—and regulation by microRNAs highlight its potential utility in stratifying tumor aggressiveness, predicting clinical outcome, and guiding targeted therapies. Moreover, these studies indicate that TAGLN may also be involved in broader pathological processes, including vascular remodeling, inflammatory responses, and the epithelial–mesenchymal transition, thereby offering insights into tumor–stroma interactions and other disease‐related cytoskeletal disturbances."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Janiel M Shields, Kelley Rogers-Graham, Channing J Der "}, {"type": "b", "children": [{"type": "t", "text": "Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110086200"}], "href": "https://doi.org/10.1074/jbc.M110086200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11773051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11773051"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Haiying Yu, Melanie Königshoff, Aparna Jayachandran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.07-083857"}], "href": "https://doi.org/10.1096/fj.07-083857"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18245174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18245174"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Stephen J Assinder, Jo-Ann L Stanton, Priya D Prasad "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin: an actin-binding protein and tumour suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2008.02.011"}], "href": "https://doi.org/10.1016/j.biocel.2008.02.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18378184"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18378184"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kai Wang, Ruijuan Xu, Jennifer Schrandt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1005591"}], "href": "https://doi.org/10.1371/journal.pgen.1005591"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26474409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26474409"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "M Elsafadi, M Manikandan, R A Dawud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin is a TGFβ-inducible gene that regulates osteoblastic and adipogenic differentiation of human skeletal stem cells through actin cytoskeleston organization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.196"}], "href": "https://doi.org/10.1038/cddis.2016.196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27490926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27490926"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Rong Liu, M Moazzem Hossain, Xuequn Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanoregulation of SM22α/Transgelin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.biochem.7b00794"}], "href": "https://doi.org/10.1021/acs.biochem.7b00794"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28898058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28898058"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lintao Zhong, Xiang He, Xiaoyun Si, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SM22α (Smooth Muscle 22α) Prevents Aortic Aneurysm Formation by Inhibiting Smooth Muscle Cell Phenotypic Switching Through Suppressing Reactive Oxygen Species/NF-κB (Nuclear Factor-κB)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.118.311917"}], "href": "https://doi.org/10.1161/ATVBAHA.118.311917"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30580562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30580562"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Weilong Zhong, Huiqin Hou, Tianyu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.44456"}], "href": "https://doi.org/10.7150/thno.44456"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32754278"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32754278"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kiyomi Tsuji-Tamura, Saori Morino-Koga, Shingo Suzuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.254920"}], "href": "https://doi.org/10.1242/jcs.254920"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34338296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34338296"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhiming Yang, Yu-Jia Chang, Hiroshi Miyamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2006-0104"}], "href": "https://doi.org/10.1210/me.2006-0104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17082327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17082327"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Na Li, Jun Zhang, Yumei Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/pr0702363"}], "href": "https://doi.org/10.1021/pr0702363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17629319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17629319"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Renaud Léguillette, Michel Laviolette, Celine Bergeron, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myosin, transgelin, and myosin light chain kinase: expression and function in asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Crit Care Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1164/rccm.200609-1367OC"}], "href": "https://doi.org/10.1164/rccm.200609-1367OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19011151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19011151"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Liang Zhao, Hui Wang, Yong-Jian Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2009.29"}], "href": "https://doi.org/10.1038/modpathol.2009.29"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19329940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19329940"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ying Lin, Phillip J Buckhaults, Jeffrey R Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.09542"}], "href": "https://doi.org/10.1593/neo.09542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19724680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19724680"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jung-Hyun Rho, Michael H A Roehrl, Julia Y Wang "}, {"type": "b", "children": [{"type": "t", "text": "Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/pr900705r"}], "href": "https://doi.org/10.1021/pr900705r"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19848416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19848416"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Priya D Prasad, Jo-Anne L Stanton, Stephen J Assinder "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-009-0902-y"}], "href": "https://doi.org/10.1007/s00441-009-0902-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20012321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20012321"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Eun-Kyung Lee, Gi-Yeon Han, Hye Won Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin promotes migration and invasion of cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/pr100378z"}], "href": "https://doi.org/10.1021/pr100378z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20707403"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20707403"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Gabriela Dos Santos Hidalgo, Juliana Meola, Júlio César Rosa E Silva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TAGLN expression is deregulated in endometriosis and may be involved in cell invasion, migration, and differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fertil Steril (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.fertnstert.2011.06.052"}], "href": "https://doi.org/10.1016/j.fertnstert.2011.06.052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21763649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21763649"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Tae Rim Kim, Eun Wie Cho, Sang Gi Paik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-induced SM22α in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.12.036"}], "href": "https://doi.org/10.1016/j.febslet.2011.12.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22245152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22245152"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Oliver Thompson, Jeelan S Moghraby, Kathryn R Ayscough, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2121-13-1"}], "href": "https://doi.org/10.1186/1471-2121-13-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22257561"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22257561"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mareike Elsner, Sandra Rauser, Stefan Maier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteomics (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jprot.2012.02.012"}], "href": "https://doi.org/10.1016/j.jprot.2012.02.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22365974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22365974"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qinmin Li, Ruihua Shi, Yundong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-012-0575-0"}], "href": "https://doi.org/10.1007/s13277-012-0575-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23138394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23138394"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Monika Dvorakova, Rudolf Nenutil, Pavel Bouchal "}, {"type": "b", "children": [{"type": "t", "text": "Transgelins, cytoskeletal proteins implicated in different aspects of cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Expert Rev Proteomics (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1586/14789450.2014.860358"}], "href": "https://doi.org/10.1586/14789450.2014.860358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24476357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24476357"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Markus Fehrholz, Christian P Speer, Steffen Kunzmann "}, {"type": "b", "children": [{"type": "t", "text": "Caffeine and rolipram affect Smad signalling and TGF-β1 stimulated CTGF and transgelin expression in lung epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0097357"}], "href": "https://doi.org/10.1371/journal.pone.0097357"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24828686"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24828686"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Mingdong Zhao, Jianshu Huang, Keke Gui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2014.1963"}], "href": "https://doi.org/10.3892/ijmm.2014.1963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25318625"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25318625"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Deepthi Rao, Bruce F Kimler, Warren B Nothnick, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2015.02.015"}], "href": "https://doi.org/10.1016/j.humpath.2015.02.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25841305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25841305"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Monika Maleszewska, Rutger A F Gjaltema, Guido Krenning, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2015.04.008"}], "href": "https://doi.org/10.1016/j.cellsig.2015.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25917318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25917318"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Jingqiu Bu, Xi Bu, Bing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.893925"}], "href": "https://doi.org/10.12659/MSM.893925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26242444"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26242444"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Qiaojia Huang, Qingling Huang, Wannan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-008-0398-y"}], "href": "https://doi.org/10.1007/s00432-008-0398-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18446369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18446369"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yves-Marie Robin, Nicolas Penel, Gaëlle Pérot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2012.192"}], "href": "https://doi.org/10.1038/modpathol.2012.192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23174934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23174934"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Huimin Zhou, Yiming Zhang, Qikui Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dig Dis Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10620-015-3985-1"}], "href": "https://doi.org/10.1007/s10620-015-3985-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26694173"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26694173"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Hui-Min Zhou, Yuan-Yuan Fang, Paul M Weinberger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-016-2105-8"}], "href": "https://doi.org/10.1186/s12885-016-2105-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26847345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26847345"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "K Wang, R Xu, A J Snider, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.36"}], "href": "https://doi.org/10.1038/cddis.2016.36"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26938296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26938296"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "D Vizlin-Hodzic, Q Zhai, S Illes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2016.284"}], "href": "https://doi.org/10.1038/tp.2016.284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28117838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28117838"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Dirk H S M Schellekens, Kostan W Reisinger, Kaatje Lenaerts, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SM22 a Plasma Biomarker for Human Transmural Intestinal Ischemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/SLA.0000000000002278"}], "href": "https://doi.org/10.1097/SLA.0000000000002278"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28525410"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28525410"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ke-Hung Tsui, Yu-Hsiang Lin, Kang-Shuo Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms20194946"}], "href": "https://doi.org/10.3390/ijms20194946"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31591355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31591355"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Mona Elsafadi, Muthurangan Manikandan, Sami Almalki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2529-6"}], "href": "https://doi.org/10.1038/s41419-020-2529-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32393769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32393769"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Xiao Wei, Hua Lou, Dongchen Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-021-02091-6"}], "href": "https://doi.org/10.1186/s13046-021-02091-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34538264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34538264"}]}]}]}
|
| Synonyms | TAGLN1, SM22, SM22-alpha, WS3-10 |
| Proteins | TAGL_HUMAN |
| NCBI Gene ID | 6876 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TAGLN has 12,043 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 124 datasets.
Click the + buttons to view associations for TAGLN from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TAGLN gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TAGLN gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TAGLN gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TAGLN gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TAGLN gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAGLN gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TAGLN protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TAGLN gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TAGLN gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TAGLN gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TAGLN gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing TAGLN protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TAGLN gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TAGLN protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing TAGLN protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TAGLN protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TAGLN protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAGLN gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TAGLN gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TAGLN gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TAGLN gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TAGLN gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TAGLN protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TAGLN gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with TAGLN gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TAGLN gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TAGLN gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TAGLN gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TAGLN gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TAGLN gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TAGLN gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TAGLN gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TAGLN gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TAGLN from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TAGLN gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TAGLN gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TAGLN gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TAGLN from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TAGLN gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TAGLN gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TAGLN gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TAGLN gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TAGLN protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TAGLN gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TAGLN gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TAGLN gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TAGLN gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TAGLN gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TAGLN gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TAGLN gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for TAGLN protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TAGLN gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TAGLN protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of TAGLN protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TAGLN from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with TAGLN gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with TAGLN gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with TAGLN gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TAGLN gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TAGLN protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TAGLN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TAGLN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TAGLN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate TAGLN protein from the curated KEA Substrates of Kinases dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate TAGLN protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAGLN gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TAGLN gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TAGLN gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TAGLN gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TAGLN gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TAGLN gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TAGLN gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TAGLN protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TAGLN gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TAGLN gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TAGLN gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TAGLN gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TAGLN gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TAGLN gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing TAGLN protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TAGLN from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TAGLN gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TAGLN gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TAGLN protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TAGLN protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with TAGLN protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate TAGLN protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving TAGLN protein from the PID Pathways dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TAGLN gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TAGLN gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TAGLN gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TAGLN gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TAGLN gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TAGLN gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with TAGLN protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TAGLN gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TAGLN gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TAGLN gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TAGLN gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TAGLN protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TAGLN protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TAGLN protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TAGLN protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TAGLN protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TAGLN protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TAGLN protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TAGLN protein from the WikiPathways Pathways 2024 dataset. | |